Lexicon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…

Biotechnology
US, The Woodlands [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of LXRX's Analysis
CIK: 1062822 CUSIP: 528872302 ISIN: US5288723027 LEI: - UEI: -
Secondary Listings
LXRX has no secondary listings inside our databases.